America’s FDA Settles Lawsuit Over Ivermectin Warnings

FDA Settles Lawsuit Over Ivermectin Posts Amid Ongoing COVID-19 Treatment Debate

In a notable turn of events, the Food and Drug Administration (FDA), a pivotal entity in the United States' health regulatory framework, has agreed to settle a high-profile lawsuit concerning its public communication about ivermectin, a drug that has been subject to widespread discussion during the COVID-19 pandemic. The settlement involves the FDA retracting certain social media posts and advisories that explicitly advised against the use of ivermectin for treating or preventing COVID-19, igniting a debate on the bounds of regulatory guidance and medical practice autonomy.